Chemical Compound
Methanone, [(7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]-; [(7R)-4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone; 5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole; Belsomra; MK 4305; [(R)-4-(5-Chloro-benzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone
CAS Registry Number
1030377-33-3
Primary record
Methanone, [(7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]-; [(7R)-4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone; 5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole; Belsomra; MK 4305; [(R)-4-(5-Chloro-benzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone
- 库存
- 1,522 克
- 纯度
- 98.1 %
- CAS
- 1030377-33-3
化合物标识与属性
- CAS
- 1030377-33-3
- PubChem CID
- 24965990
- SMILES
- C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl
- Canonical SMILES
- Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1
名称与同义词
- Suvorexant
- BELSOMRA
- MK-4305
- 1030377-33-3
- suvorexantum
- Belsomra (TN)
- MK4305
- MK 4305
- Suvorexant (MK-4305)
- Suvorexant [USAN:INN]
- Suvorexant Impurity 19
- -2-yl)phenyl)methanone
- C23H23ClN6O2
- RefChem:56329
- SUVOREXANT [MI]
- SUVOREXANT [INN]
- SUVOREXANT [JAN]
- Suvorexant (JAN/USAN)
- SUVOREXANT [USAN]
- Suvorexant; MK 4305
- SUVOREXANT [VANDF]
- D00OVU
- SUVOREXANT [WHO-DD]
- CHEMBL1083659
- UNII-081L192FO9
- CHEBI:82698
- orb146219
- DTXSID90145616
- MFCD22377755
- AMY337
- GTPL2890
- SCHEMBL1586289
- 081L192FO9
- BELSOMRA COMPONENT SUVOREXANT
- DTXCID0068107
- SCHEMBL13372948
- SCHEMBL29357712
- SUVOREXANT [ORANGE BOOK]
- EX-A211
- N05CM19
- QCR-177
- JYTNQNCOQXFQPK-MRXNPFEDSA-N
- 2737AH
- BDBM50318701
- ZINC49036447
- AKOS022185167
- ACN-029994
- CS-0614
- DB09034
- FS65089
- KS-0000062S
- NCGC00386302-04
- AC-30276
- AS-74879
- BC600366
- CID:24965990
- HY-10807
- SC-94530
- BCP0726000197
- SID:461822932
- AB0072958
- AJ-110996
- ST2401560
- A3616
- NS00067952
- SW219649-1
- [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone
- J2.846.988H
- A11500
- D10082
- W-5905
- (R)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
- 5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole
- C551624
- A1098651
- Q7650517
- BRD-K94293891-001-01-3
- CAS:1030377-33-3;MK-4305
- ((7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
- (4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone
- [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
- Methanone, ((7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)-
- (R)-(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone.
- Methanone, [(7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-Methyl-1H-1,4-diazepin-1-yl][5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]-
- (R)-(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol
- [(7R)-[4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepine-1-yl]][5-methyl-2-(2H-1,2,3-triazole-2-yl)phenyl]methanone
- [(7R)-[4-(5-Chlorobenzoxazole-2-yl)hexahydro-7-methyl-1H-1,4-diazepine-1-yl]][5-methyl-2-(2H-1,2,3-triazole-2-yl)phenyl]methanone
- [(7R)-4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone
- [(R)-4-(5-Chloro-benzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone
- [2-(2H-1,2,3-Triazole-2-yl)-5-methylphenyl][(7R)-4-(5-chlorobenzoxazole-2-yl)-7-methylhexahydro-1H-1,4-diazepine-1-yl] ketone
- 1-(5-Chlorobenzoxazole-2-yl)-4-[5-methyl-2-(2H-1,2,3-triazole-2-yl)benzoyl]-5alpha-methyl-1,4-diazacycloheptane
- 2762965-03-5
- 5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole MK 4305
- 5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazole-2-yl)benzoyl]-hexahydro-1H-1,4-diazepine-1-yl]-benzoxazole
- Methanone, [(7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]-; [(7R)-4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone; 5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole; Belsomra; MK 4305; [(R)-4-(5-Chloro-benzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone
- SUV